Summary of Purpose
This is a single-arm, open-labeled and phase II futility study. Application of Remote ischemic conditioning (RIC) as an adjunctive therapy to medication were involved in the study. The study is to test whether RIC is effective in preventing ischemic evens after a minor ischemic stroke/transient ischemic attack within 3 months and to explore the safety and compliance of chronic RIC. Medication strategy is based on...Read More →
The following dates are available for this trial. Trial information last updated on 29 January 2018.
|6 Dec 2016||10 Dec 2016||19 Oct 2017||19 Oct 2017||1 Jan 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Xunming Ji, MD, PhD
- Shimeng Liu, MD, MSCR